Education
About Us
Working with TipRanks
Follow Us
Lotus Pharmaceuticals Inc (LTUS)
OTHER OTC:LTUS
Total Valuation
Lotus Pharmaceuticals has a market cap or net worth of $223.36K. The enterprise value is ―.
Market Cap$223.36K
Enterprise Value―
Share Statistics
Lotus Pharmaceuticals has 27,816,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding27,816,000
Owned by Insiders―
Owned by Institutions0.14%
Financial Efficiency
Lotus Pharmaceuticals’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 2623.96%.
Return on Equity (ROE)0.17
Return on Assets (ROA)-3.31
Return on Invested Capital (ROIC)2623.96%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee0.00
Profits Per Employee-80.74
Employee Count233
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Lotus Pharmaceuticals is ―. Lotus Pharmaceuticals’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value-103.17
Price to FCF0.00
Price to Operating Cash Flow-1.93K
PEG Ratio―
Income Statement
In the last 12 months, Lotus Pharmaceuticals had revenue of 0.00 and earned -18.81K in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-18.81K
Pretax Income-18.81K
Net Income-18.81K
EBITDA-18.81K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -16.40K and capital expenditures 0.00, giving a free cash flow of -16.40K billion.
Operating Cash Flow-16.40K
Free Cash Flow-16.40K
Free Cash Flow per Share>-0.01
Dividends & Yields
Lotus Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-4.27
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)82.51K
Important Dates
Lotus Pharmaceuticals upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Lotus Pharmaceuticals as a current ratio of 0.05, with Debt / Equity ratio of -103.52%
Current Ratio0.05
Quick Ratio0.05
Debt to Market Cap0.01
Net Debt to EBITDA-6.10
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Lotus Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate8.92
Enterprise Valuation
Lotus Pharmaceuticals EV to EBITDA ratio is -614.91, with an EV/FCF ratio of -604.56.
EV to Sales0.00
EV to EBITDA-614.91
EV to Free Cash Flow-604.56
EV to Operating Cash Flow-604.56
Balance Sheet
Lotus Pharmaceuticals has $419.00 in cash and marketable securities with ― in debt, giving a net cash position of $123.01K billion.
Cash & Marketable Securities$419.00
Total Debt―
Net Cash$123.01K
Net Cash Per Share<$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Lotus Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―